Staging of Non-Small Cell Lung Cancer

Lynn T. Tanoue

doi:10.1055/s-2008-1076745

Seminars in Respiratory and Critical Care Medicine, Inhaltsverzeichnis

Semin Respir Crit Care Med 2008; 29(3): 248-260
DOI: 10.1055/s-2008-1076745

Staging of Non-Small Cell Lung Cancer

Lynn T. Tanoue¹

¹Section of Pulmonary and Critical Care Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut

Abstract

ABSTRACT

Accurate clinical staging is critical in the evaluation of any patient with non-small cell lung cancer (NSCLC). Staging for NSCLC is based on the tumor, node, metastasis (TNM) system used for most solid tumors. The clinical stage, as determined by all available clinical, radiographic, and biopsy data, provides patients and physicians with an overall assessment of disease extent and prediction of survival and enables the identification of appropriate therapies. It is thus imperative that staging be performed as accurately and comprehensively as possible while also maintaining efficiency. To do so requires an understanding of the staging system, the clinical clues that drive the staging evaluation, and a working knowledge of available noninvasive and invasive diagnostic modalities.

KEYWORDS

Lung cancer - staging - PET scanning - CT scanning

Volltext

Referenzen

REFERENCES

1 Mountain C F. Revisions in the International System for Staging Lung Cancer. Chest. 1997; 111 1710-1717
2 Denoix P. Enquete permanente dans les centres anti-cancereux. Bull Inst Natl Hyg. 1946; 1 70
3 Mountain C F, Dresler C M. Regional lymph node classification for lung cancer staging. Chest. 1997; 111 1718-1723
4 Martini N, Bains M S, Burt M E et al.. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995; 109 120-129
5 Henschke C I, Yankelevitz D F, Libby D M, Pasmantier M W, Smith J P, Miettinen O S. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006; 355 1763-1771
6 Mulshine J L, Sullivan D C. Clinical practice: lung cancer screening. N Engl J Med. 2005; 352 2714-2720
7 Rami-Porta R, Ball D, Crowley J et al.. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2007; 2 593-602
8 Gould M K, Kuschner W G, Rydzak C E et al.. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small cell lung cancer: a meta-analysis. Ann Intern Med. 2003; 139 879-892
9 Dwamena B A, Sonnad S S, Angobaldo J O, Wahl R L. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s–meta-analytic comparison of PET and CT. Radiology. 1999; 213 530-536
10 Toloza E M, Harpole L, McCrory D C. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest. 2003; 123(1 Suppl) 137S-146S
11 Silvestri G A, Gould M K, Margolis M L et al.. Noninvasive staging of non-small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132 178S-201S
12 Shafazand S, Gould M K. A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer. J Thorac Oncol. 2006; 1 953-959
13 Detterbeck F, Jones D, Parker L. Intrathoracic staging. In: Detterbeck F, Rivera MP, Socinski M Diagnosis and Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing Clinician. Philadelphia; WB Saunders 2001: 73-93
14 Webb W R, Gatsonis C, Zerhouni E A et al.. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology. 1991; 178 705-713
15 Padovani B, Mouroux J, Seksik L et al.. Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging. Radiology. 1993; 187 33-38
16 Silvestri G A, Lenz J E, Harper S N, Morse R A, Colice G L. The relationship of clinical findings to CT scan evidence of adrenal gland metastases in the staging of bronchogenic carcinoma. Chest. 1992; 102 1748-1751
17 Silvestri G A, Littenberg B, Colice G L. The clinical evaluation for detecting metastatic lung cancer: a meta-analysis. Am J Respir Crit Care Med. 1995; 152 225-230
18 Grant D, Edwards D, Goldstraw P. Computed tomography of the brain, chest, and abdomen in the preoperative assessment of non-small cell lung cancer. Thorax. 1988; 43 883-886
19 Detterbeck F C, Jantz M A, Wallace M, Vansteenkiste J, Silvestri G A. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132(3 Suppl) 202S-220S
20 Coughlin M, Deslauriers J, Beaulieu M et al.. Role of mediastinoscopy in pretreatment staging of patients with primary lung cancer. Ann Thorac Surg. 1985; 40 556-560
21 Gdeedo A, Van Schil P, Corthouts B, Van Mieghem F, Van Meerbeeck J, Van Marck E. Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. Eur Respir J. 1997; 10 1547-1551
22 Toloza E M, Harpole L, Detterbeck F, McCrory D C. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest. 2003; 123(1 Suppl) 157S-166S
23 Page A, Nakhle G, Mercier C et al.. Surgical treatment of bronchogenic carcinoma: the importance of staging in evaluating late survival. Can J Surg. 1987; 30 96-99
24 Deneffe G, Lacquet L M, Gyselen A. Cervical mediastinoscopy and anterior mediastinotomy in patients with lung cancer and radiologically normal mediastinum. Eur J Respir Dis. 1983; 64 613-619
25 Sebastian-Quetglas F, Molins L, Baldo X, Buitrago J, Vidal G. Clinical value of video-assisted thoracoscopy for preoperative staging of non-small cell lung cancer: a prospective study of 105 patients. Lung Cancer. 2003; 42 297-301
26 Roberts J R, Blum M G, Arildsen R et al.. Prospective comparison of radiologic, thoracoscopic, and pathologic staging in patients with early non-small cell lung cancer. Ann Thorac Surg. 1999; 68 1154-1158
27 Massone P P, Lequaglie C, Magnani B, Ferro F, Cataldo I. The real impact and usefulness of video-assisted thoracoscopic surgery in the diagnosis and therapy of clinical lymphadenopathies of the mediastinum. Ann Surg Oncol. 2003; 10 1197-1202
28 Gupta S, Seaberg K, Wallace M J et al.. Imaging-guided percutaneous biopsy of mediastinal lesions: different approaches and anatomic considerations. Radiographics. 2005; 25 763-786 discussion 786-788
29 Zwischenberger J B, Savage C, Alpard S K, Anderson C M, Marroquin S, Goodacre B W. Mediastinal transthoracic needle and core lymph node biopsy: should it replace mediastinoscopy?. Chest. 2002; 121 1165-1170
30 Westcott J L. Percutaneous needle aspiration of hilar and mediastinal masses. Radiology. 1981; 141 323-329
31 Protopapas Z, Westcott J L. Transthoracic needle biopsy of mediastinal lymph nodes for staging lung and other cancers. Radiology. 1996; 199 489-496
32 LeBlanc J K, Devereaux B M, Imperiale T F et al.. Endoscopic ultrasound in non-small cell lung cancer and negative mediastinum on computed tomography. Am J Respir Crit Care Med. 2005; 171 177-182
33 Wallace M B, Ravenel J, Block M I et al.. Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography. Ann Thorac Surg. 2004; 77 1763-1768
34 Singh P, Camazine B, Jadhav Y et al.. Endoscopic ultrasound as a first test for diagnosis and staging of lung cancer: a prospective study. Am J Respir Crit Care Med. 2007; 175 345-354
35 Rintoul R C, Skwarski K M, Murchison J T, Wallace W A, Walker W S, Penman I D. Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal staging. Eur Respir J. 2005; 25 416-421
36 Yasufuku K, Chiyo M, Sekine Y et al.. Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest. 2004; 126 122-128
37 Yasufuku K, Nakajima T, Motoori K et al.. Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer. Chest. 2006; 130 710-718
38 Herth F J, Eberhardt R, Vilmann P, Krasnik M, Ernst A. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax. 2006; 61 795-798
39 Davis P C, Hudgins P A, Peterman S B, Hoffman Jr J C. Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 1991; 12 293-300
40 Jennings E C, Aungst C W, Yatco R. Asymptomatic patients with primary carcinoma: computerized axial tomography study. N Y State J Med. 1980; 80(7 Pt 1) 1096-1098
41 Ferrigno D, Buccheri G. Cranial computed tomography as a part of the initial staging procedures for patients with non-small cell lung cancer. Chest. 1994; 106 1025-1029
42 Kormas P, Bradshaw J R, Jeyasingham K. Preoperative computed tomography of the brain in non-small cell bronchogenic carcinoma. Thorax. 1992; 47 106-108
43 Shahidi H, Kvale P A. Long-term survival following surgical treatment of solitary brain metastasis in non-small cell lung cancer. Chest. 1996; 109 271-276
44 Nielsen Jr M E, Heaston D K, Dunnick N R, Korobkin M. Preoperative CT evaluation of adrenal glands in non-small cell bronchogenic carcinoma. AJR Am J Roentgenol. 1982; 139 317-320
45 Hedeland H, Ostberg G, Hokfelt B. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand. 1968; 184 211-214
46 Herrera M F, Grant C S, van Heerden J A, Sheedy P F, Ilstrup D M. Incidentally discovered adrenal tumors: an institutional perspective. Surgery. 1991; 110 1014-1021
47 Dunnick N R, Korobkin M, Francis I. Adrenal radiology: distinguishing benign from malignant adrenal masses. AJR Am J Roentgenol. 1996; 167 861-867
48 Urschel J D, Finley R K, Takita H. Long-term survival after bilateral adrenalectomy for metastatic lung cancer: a case report. Chest. 1997; 112 848-850
49 Shen K R, Meyers B F, Larner J M, Jones D R. Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007; 132(3 Suppl) 290S-305S
50 Porte H, Siat J, Guibert B et al.. Resection of adrenal metastases from non-small cell lung cancer: a multicenter study. Ann Thorac Surg. 2001; 71 981-985
51 Schirrmeister H, Arslandemir C, Glatting G et al.. Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 2004; 31 964-968
52 Hsia T C, Shen Y Y, Yen R F, Kao C H, Changlai S P. Comparing whole body 18F–2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Neoplasma. 2002; 49 267-271
53 Rusch V W, Crowley J, Giroux D J et al.. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2007; 2 603-612
54 Winton T, Livingston R, Johnson D et al.. Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer. N Engl J Med. 2005; 352 2589-2597
55 Douillard J Y, Rosell R, De Lena M et al.. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol. 2006; 7 719-727
56 Okumura T, Asamura H, Suzuki K, Kondo H, Tsuchiya R. Intrapulmonary metastasis of non-small cell lung cancer: a prognostic assessment. J Thorac Cardiovasc Surg. 2001; 122 24-28
57 Pisters K, Darling G. The IASLC Lung Cancer Staging Project: the nodal zone. J Thorac Oncol. 2007; 2 583-584

Lynn T TanoueM.D.

Section of Pulmonary and Critical Care Medicine, Yale School of Medicine, Yale University

105 LCI, 333 Cedar St., New Haven, CT 06520

eMail: lynn.tanoue@yale.edu